Your browser doesn't support javascript.
loading
Extracellular vesicles as drug delivery systems: Why and how?
Elsharkasy, Omnia M; Nordin, Joel Z; Hagey, Daniel W; de Jong, Olivier G; Schiffelers, Raymond M; Andaloussi, Samir El; Vader, Pieter.
Afiliação
  • Elsharkasy OM; CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Nordin JZ; Department of Laboratory Medicine, Group of Biomolecular Medicine, Karolinska Institutet, Huddinge, Sweden; Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
  • Hagey DW; Department of Laboratory Medicine, Group of Biomolecular Medicine, Karolinska Institutet, Huddinge, Sweden.
  • de Jong OG; CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Schiffelers RM; CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Andaloussi SE; Department of Laboratory Medicine, Group of Biomolecular Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Vader P; CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: pvader@umcutrecht.nl.
Adv Drug Deliv Rev ; 159: 332-343, 2020.
Article em En | MEDLINE | ID: mdl-32305351
ABSTRACT
Over the past decades, a multitude of synthetic drug delivery systems has been developed and introduced to the market. However, applications of such systems are limited due to inefficiency, cytotoxicity and/or immunogenicity. At the same time, the field of natural drug carrier systems has grown rapidly. One of the most prominent examples of such natural carriers are extracellular vesicles (EVs). EVs are cell-derived membranous particles which play important roles in intercellular communication. EVs possess a number of characteristics that qualify them as promising vehicles for drug delivery. In order to take advantage of these attributes, an in-depth understanding of why EVs are such unique carrier systems and how we can exploit their qualities is pivotal. Here, we review unique EV features that are relevant for drug delivery and highlight emerging strategies to make use of those features for drug loading and targeted delivery.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Vesículas Extracelulares Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Vesículas Extracelulares Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda